Table 4.

Correlation Matrix for ADCS Scales and Study Variables

Internal Support	Baseline (n=323)	6-month (n=242)	12-month (n=234)
ASI Alcohol	.14*	.17*	.21**
ASI Drug	.16**	.13*	.22**
GSI	.13*	.23***	.26***
ADCQ Costs	.25***	.21**	.28***
ADCQ Benefits	.03	.19**	.12
Peak Density	.15**	.17**	.23***
External Intensity
ASI Alcohol	.16**	.21**	.22**
ASI Drug	.17**	.17**	.23***
GSI	.18**	.26***	.28***
ADCQ Costs	.23***	.20**	.29***
ADCQ Benefits	.09	.19**	.14*
Peak Density	.16**	.18**	24***

^*p<.05

^**p<.01

^***p<.001

Note: Participants with no confrontation coded 0